Chemical Probes That Modulate Phosphatidylinositol-5-Phosphate 4-Kinase Activity
调节磷脂酰肌醇 5 磷酸 4 激酶活性的化学探针
基本信息
- 批准号:8403186
- 负责人:
- 金额:$ 3.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-01-01 至 2013-12-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAntineoplastic AgentsBiological AssayBreast Cancer ModelCancer ModelCell ProliferationCellsChemicalsDataData AnalysesDevelopmentEmbryoFamilyFibroblastsFirefly LuciferasesGoalsGrantHumanKnockout MiceLettersMalignant NeoplasmsMalignant neoplasm of prostateMeasuresMetabolismMethodsModelingMusNaturePIP5K2A genePathway interactionsPhosphotransferasesPrincipal InvestigatorProductionPromegaPropertyProto-Oncogene Proteins c-aktRadiolabeledRegulationSeriesSignal TransductionSpecificityStressStructureStructure-Activity RelationshipTestingTitrationsanalogbasecancer cellcancer typecell growthhigh throughput screeningimprovedin vivoinhibitor/antagonistinsulin signalingmouse modelneoplastic cellnovelnovel strategiesphosphatidylinositol 3-phosphatephosphatidylinositol 4-phosphatephosphatidylinositol 5-phosphateprogramspublic health relevanceradiotracerresponsescreeningsmall moleculetumortumor growth
项目摘要
DESCRIPTION (provided by applicant): This proposal aims to identify and optimize specific modulators of human PI5P4K, phosphatidylinositol- 5-phosphate 4-kinase (Type II PIPK), a family of kinases that regulate AKT signaling and tumor cell growth. The following specific aims will be pursued: (1) to identify inhibitors of human PI5P4K using a quantitative high-throughput screening approach against the MLSMR containing ~400,000 small molecules. (2) To validate the potency of the identified compounds in a panel of secondary assays, which consist of selectivity assays to identify those compounds that do not affect PI4P5K, phosphatidylinositol- 4-phosphate 5-kinase (Type I PIPK), and PI3P5K, the phosphatidylinositol-3-phosphate 5-kinase (Type III PIPK /Fab1/PIKfyve). We will test the impact and specificity of these PI5P4K probes on cellular PI5P accumulation and cell proliferation using PI5P4K knockout mouse embryonic fibroblasts (MEFs) and knockdown cells as controls. (3) Beyond the granting term for this proposal, to examine the most potent PI5P4K probes for their ability to decrease tumor growth in mouse models of cancer.
描述(由申请人提供):该提案旨在鉴定和优化人类PI5P4K,磷脂酰肌醇- 5-磷酸4激酶(II型PIPK)的特异性调节剂,这是一个调节AKT信号传导和肿瘤细胞生长的激酶家族。以下具体目标将被追求:(1)使用定量高通量筛选方法针对含有约400,000个小分子的MLSMR鉴定人类PI5P4K抑制剂。(2)在一组二级分析中验证鉴定的化合物的效价,二级分析包括选择性分析,以鉴定不影响PI4P5K,磷脂酰肌醇- 4-磷酸5激酶(I型PIPK)和PI3P5K,磷脂酰肌醇-3-磷酸5激酶(III型PIPK /Fab1/PIKfyve)的化合物。我们将使用PI5P4K敲除小鼠胚胎成纤维细胞(mef)和敲除细胞作为对照,测试这些PI5P4K探针对细胞PI5P积累和细胞增殖的影响和特异性。(3)在本提案的授权期限之外,研究最有效的PI5P4K探针在小鼠癌症模型中降低肿瘤生长的能力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Atsuo Sasaki其他文献
Atsuo Sasaki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Atsuo Sasaki', 18)}}的其他基金
Mechanistic role of phosphatidylinositol 5-phosphate 4-kinase beta in GTP-dependent lysosomal acidification for stress-resilient cell growth and metabolism
磷脂酰肌醇5-磷酸4-激酶β在GTP依赖性溶酶体酸化对应激恢复细胞生长和代谢中的机制作用
- 批准号:
10592707 - 财政年份:2022
- 资助金额:
$ 3.83万 - 项目类别:
Mechanistic role of phosphatidylinositol 5-phosphate 4-kinase beta in GTP-dependent lysosomal acidification for stress-resilient cell growth and metabolism
磷脂酰肌醇5-磷酸4-激酶β在GTP依赖性溶酶体酸化中对应激恢复细胞生长和代谢的机制作用
- 批准号:
10797540 - 财政年份:2022
- 资助金额:
$ 3.83万 - 项目类别:
Therapeutic resistance and aggressive malignancy in glioblastomas: the contribution of GTP metabolism through regulation by IMPDH2
胶质母细胞瘤的治疗耐药性和侵袭性恶性肿瘤:IMPDH2 调节 GTP 代谢的贡献
- 批准号:
10682618 - 财政年份:2021
- 资助金额:
$ 3.83万 - 项目类别:
Therapeutic resistance and aggressive malignancy in glioblastomas: the contribution of GTP metabolism through regulation by IMPDH2
胶质母细胞瘤的治疗耐药性和侵袭性恶性肿瘤:IMPDH2 调节 GTP 代谢的贡献
- 批准号:
10296056 - 财政年份:2021
- 资助金额:
$ 3.83万 - 项目类别:
Therapeutic resistance and aggressive malignancy in glioblastomas: the contribution of GTP metabolism through regulation by IMPDH2
胶质母细胞瘤的治疗耐药性和侵袭性恶性肿瘤:IMPDH2 调节 GTP 代谢的贡献
- 批准号:
10447195 - 财政年份:2021
- 资助金额:
$ 3.83万 - 项目类别:
Synthetic Lethal Combination of KRP203/Fingolimod with PI3K signaling for glioblastoma multiforme death by catastrophic vacuolization
KRP203/芬戈莫德与 PI3K 信号传导的合成致死组合可导致多形性胶质母细胞瘤灾难性空泡化死亡
- 批准号:
9335996 - 财政年份:2016
- 资助金额:
$ 3.83万 - 项目类别:
Synthetic Lethal Combination of KRP203/Fingolimod with PI3K signaling for glioblastoma multiforme death by catastrophic vacuolization
KRP203/芬戈莫德与 PI3K 信号传导的合成致死组合可导致多形性胶质母细胞瘤灾难性空泡化死亡
- 批准号:
9227435 - 财政年份:2016
- 资助金额:
$ 3.83万 - 项目类别:
Targeting the Novel PI5P4K Pathway to Induce Glioblastoma Senescence
靶向新的 PI5P4K 途径诱导胶质母细胞瘤衰老
- 批准号:
8935962 - 财政年份:2014
- 资助金额:
$ 3.83万 - 项目类别:
Targeting the Novel PI5P4K Pathway to Induce Glioblastoma Senescence
靶向新的 PI5P4K 途径诱导胶质母细胞瘤衰老
- 批准号:
8800075 - 财政年份:2014
- 资助金额:
$ 3.83万 - 项目类别:
Chemical probes that modulate a stress pathway phosphatidylinositol 5-phosphate 4
调节应激途径磷脂酰肌醇 5-磷酸 4 的化学探针
- 批准号:
8262562 - 财政年份:2012
- 资助金额:
$ 3.83万 - 项目类别:
相似海外基金
Delays in Acquisition of Oral Antineoplastic Agents
口服抗肿瘤药物的获取延迟
- 批准号:
9975367 - 财政年份:2020
- 资助金额:
$ 3.83万 - 项目类别:
Eliminate the difficulty of venous puncture in patients receiving antineoplastic agents - Development of a new strategy for the prevention of induration-
消除接受抗肿瘤药物的患者静脉穿刺的困难 - 制定预防硬结的新策略 -
- 批准号:
16K11932 - 财政年份:2016
- 资助金额:
$ 3.83万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms of the antineoplastic agents inhibiting DNA replication and their applications to cancer patient treatmen
抗肿瘤药物抑制DNA复制的分子机制及其在癌症患者治疗中的应用
- 批准号:
19591274 - 财政年份:2007
- 资助金额:
$ 3.83万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
PNET EXPERIMENTAL THERAPEUTICS--ANTINEOPLASTIC AGENTS AND TREATMENT DELIVERY
PNET 实验治疗——抗肿瘤药物和治疗实施
- 批准号:
6346309 - 财政年份:2000
- 资助金额:
$ 3.83万 - 项目类别:
TYROSINE KINASE INHIBITORS AS ANTINEOPLASTIC AGENTS
酪氨酸激酶抑制剂作为抗肿瘤剂
- 批准号:
2885074 - 财政年份:1999
- 资助金额:
$ 3.83万 - 项目类别:
TYROSINE KINASE INHIBITORS AS ANTINEOPLASTIC AGENTS
酪氨酸激酶抑制剂作为抗肿瘤剂
- 批准号:
6174221 - 财政年份:1999
- 资助金额:
$ 3.83万 - 项目类别:














{{item.name}}会员




